Literature DB >> 1919600

Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis.

F Duarte1, S Binet, L Lacomblez, P Bouche, J L Preud'homme, V Meininger.   

Abstract

In a prospective study, we analysed the presence of monoclonal immunoglobulin (moIg) in the serum from 30 patients with amyotrophic lateral sclerosis (ALS) and 30 matched controls using a sensitive Western blot technique. The incidence of serum moIg was 60% in the ALS group and 13.3% in the control group. Most ALS sera contained 2 or 3 monoclonal components. They were IgG (72.7%) and IgM (27.3%). These results corroborate the concept of a probable association between ALS and serum moIg.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919600     DOI: 10.1016/0022-510x(91)90220-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

3.  Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study.

Authors:  Lotte Vlam; Sanne Piepers; Nadia A Sutedja; Bart C Jacobs; Anne P Tio-Gillen; Marloes Stam; Hessel Franssen; Jan H Veldink; Elisabeth A Cats; Nicolette C Notermans; Andries C Bloem; Renske I Wadman; W-Ludo van der Pol; Leonard H van den Berg
Journal:  J Neurol       Date:  2015-01-01       Impact factor: 4.849

Review 4.  Inflammation in ALS/FTD pathogenesis.

Authors:  Madelyn E McCauley; Robert H Baloh
Journal:  Acta Neuropathol       Date:  2018-11-21       Impact factor: 17.088

Review 5.  Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination?

Authors:  S Petratos; M E Gonzales
Journal:  Neuropathology       Date:  2000-12       Impact factor: 1.906

6.  Humoral immune activation in amyotrophic lateral sclerosis patients.

Authors:  Michael Rentzos; Maria Eleftheria Evangelopoulos; Eleni Sereti; Vassiliki Zouvelou; Styliani Marmara; Theodoros Alexakis; Ioannis Evdokimidis
Journal:  Neurol Int       Date:  2013-02-11

Review 7.  Novel molecular biomarkers at the blood-brain barrier in ALS.

Authors:  Danijela Bataveljic; Milena Milosevic; Lidija Radenovic; Pavle Andjus
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.